# Leo Medical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/leo-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Changzhou, China
- Website: www.leomed.cn
- Total disclosed funding: $11M
- Latest round: Series C (Jun 28, 2021)
- Investors on record: 7

## About

Established in 2011 and based in Changzhou, China, Leo Medical Co., Ltd. is a medical device manufacturer that focuses on the research and development of medical devices. The company has a metal stent technology platform, a balloon catheter polymer technology platform, a drug-loading technology platform and an active device technology platform.

The company engages in the research and development of peripheral vascular interventional, digestive endoscopic interventional and respiratory endoscopic interventional devices. Its main products include ERCP product suite, EMR product suite and ESD product suite. ERCP products are used for the treatment of pancreatic biliary system diseases, EMR and ESD products are used for minimally invasive treatment of benign and early malignant lesions of the esophagus, stomach and colon.

## Funding rounds

- Series C, Jun 28, 2021 — China International Capital Corporation, Sunland Capital
- Series B, Jul 7, 2015, $7.3M — LYFE Capital, Chuangpai Capital, Shanghai Jinyi Investment Management Co., Ltd.
- Series A, Jul 6, 2014, $3.2M — IDG Capital, Cowin Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- LYFE Capital — Series B
- Chuangpai Capital — Series B
- Shanghai Jinyi Investment Management Co., Ltd. — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Sunland Capital — Series C